Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phreesia (PHR) Research & Development (2018 - 2025)

Phreesia's Research & Development history spans 8 years, with the latest figure at $29.5 million for Q4 2025.

  • For Q4 2025, Research & Development changed 0.47% year-over-year to $29.5 million; the TTM value through Oct 2025 reached $120.2 million, up 2.2%, while the annual FY2025 figure was $117.4 million, 4.47% up from the prior year.
  • Research & Development for Q4 2025 was $29.5 million at Phreesia, up from $29.3 million in the prior quarter.
  • Across five years, Research & Development topped out at $31.8 million in Q2 2025 and bottomed at $6.4 million in Q1 2021.
  • The 5-year median for Research & Development is $27.0 million (2023), against an average of $23.5 million.
  • The largest annual shift saw Research & Development skyrocketed 175.3% in 2022 before it decreased 0.91% in 2025.
  • A 5-year view of Research & Development shows it stood at $15.3 million in 2021, then surged by 48.43% to $22.7 million in 2022, then increased by 25.92% to $28.5 million in 2023, then rose by 2.7% to $29.3 million in 2024, then rose by 0.47% to $29.5 million in 2025.
  • Per Business Quant, the three most recent readings for PHR's Research & Development are $29.5 million (Q4 2025), $29.3 million (Q3 2025), and $31.8 million (Q2 2025).